The content of the training

In this topical webinar, we will discuss the following new active ingredients: Enfortumab vedotin, sotorasib, pirtobrutinib, entrectinib, and lutetium (177Lu) oxodotreotide.

Overview of new pharmaceuticals according to the theme of the webinar
Elli Leppä, PhD, Development Pharmacist, Pharmaca Health Intelligence Oy 

New pharmaceuticals from an expert's perspective and discussion
Sauli Vuoti, PhD, Docent, Professor of practice in Oncology, University of Jyväskylä / Hospital Nova 
Elli Leppä, PhD, Development Pharmacist, Pharmaca Health Intelligence Oy 

In the training we will dive into the indication for drug use, drug formulation, dosage and administration, side effects, as well as pharmacodynamics and pharmacokinetics. Additionally, we will explore the positioning of pharmaceuticals within their therapeutic groups. Furthermore, we will address other topics such as contraindications and drug interactions.

The expert speakers 

Sauli Vuoti
The trainer of this education, Sauli Vuoti, PhD, is a Professor of Practice in Oncology at the University of Jyväskylä and Sairaala Nova, alongside being a docent in clinical pharmaceutical chemistry and biomedicine. With a background in leading oncology research groups at the University of Oulu and the University of Jyväskylä, Vuoti has garnered extensive experience in both domestic and international roles within various pharmaceutical companies. His research has primarily focused on breast and liver cancers, glioblastoma, and multiple myeloma. Vuoti is also recognized for his contribution to science through the creation of acclaimed science podcast series titled “Science with Emotion” and “From Science to the Real World”. 

Elli Leppä
Elli Leppä, PhD, is a Development Pharmacist with over a decade of expertise in developing medical information tools and services tailored for healthcare professionals and consumers. Her areas of specialization encompass curating pharmacological information into user-friendly and clinically effective formats. Elli earned her doctoral degree in neuropharmacology from the Faculty of Medicine at the University of Helsinki in 2011.